Cargando…

Associated factors for discussing advance directives with family physicians by noncancer outpatients in Japan

BACKGROUND: Advance directives (ADs) are seldom discussed between primary care physicians (PCPs) and their patients, especially those with noncancer diseases. The aim was to identify the factors associated with discussing AD by noncancer patients with their physicians. METHODS: This cross‐sectional...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamada, Shuhei, Haruta, Junji, Hamano, Jun, Maeno, Takami, Maeno, Tetsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498101/
https://www.ncbi.nlm.nih.gov/pubmed/31065472
http://dx.doi.org/10.1002/jgf2.238
_version_ 1783415579985575936
author Hamada, Shuhei
Haruta, Junji
Hamano, Jun
Maeno, Takami
Maeno, Tetsuhiro
author_facet Hamada, Shuhei
Haruta, Junji
Hamano, Jun
Maeno, Takami
Maeno, Tetsuhiro
author_sort Hamada, Shuhei
collection PubMed
description BACKGROUND: Advance directives (ADs) are seldom discussed between primary care physicians (PCPs) and their patients, especially those with noncancer diseases. The aim was to identify the factors associated with discussing AD by noncancer patients with their physicians. METHODS: This cross‐sectional study was conducted in a hospital or clinic from October to December 2017. Physicians chose eligible noncancer patients aged 20 years or older to respond to an anonymous self‐completed questionnaire inquiring about the objective variable “I want to discuss AD with my doctor,” as well as basic characteristics, and facilitators and barriers to discussing AD identified in previous studies. The physicians responded to a survey comprising the Palliative Performance Scale (PPS) and inquiring about the disease category for each patient. Data were analyzed using binomial logistic regression analysis. RESULTS: A total of 270 patients (valid response rate, 79.6%) were included. Multivariate analysis identified a period of visit to the study site ≥ 3 years (odds ratio [OR], 2.07; 95% confidence interval [CI], 1.05‐4.10), physicians who are very good at taking care of patients’ disease (OR, 12.68; 95% CI, 1.12‐143.22), and patients’ worry about their quality of life (QOL) in the future (OR, 2.69; 95% CI, 1.30‐5.57) as facilitators for discussing AD with physicians, and PPS ≤ 90 (OR, 0.51; 95% CI, 0.26‐0.98) as a barrier. CONCLUSIONS: Our study indicates that patients’ future QOL concerns, a long period of visit to a hospital, and the presence of physical symptoms were associated with the willingness of noncancer patients to discuss AD with PCPs.
format Online
Article
Text
id pubmed-6498101
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64981012019-05-07 Associated factors for discussing advance directives with family physicians by noncancer outpatients in Japan Hamada, Shuhei Haruta, Junji Hamano, Jun Maeno, Takami Maeno, Tetsuhiro J Gen Fam Med Original Articles BACKGROUND: Advance directives (ADs) are seldom discussed between primary care physicians (PCPs) and their patients, especially those with noncancer diseases. The aim was to identify the factors associated with discussing AD by noncancer patients with their physicians. METHODS: This cross‐sectional study was conducted in a hospital or clinic from October to December 2017. Physicians chose eligible noncancer patients aged 20 years or older to respond to an anonymous self‐completed questionnaire inquiring about the objective variable “I want to discuss AD with my doctor,” as well as basic characteristics, and facilitators and barriers to discussing AD identified in previous studies. The physicians responded to a survey comprising the Palliative Performance Scale (PPS) and inquiring about the disease category for each patient. Data were analyzed using binomial logistic regression analysis. RESULTS: A total of 270 patients (valid response rate, 79.6%) were included. Multivariate analysis identified a period of visit to the study site ≥ 3 years (odds ratio [OR], 2.07; 95% confidence interval [CI], 1.05‐4.10), physicians who are very good at taking care of patients’ disease (OR, 12.68; 95% CI, 1.12‐143.22), and patients’ worry about their quality of life (QOL) in the future (OR, 2.69; 95% CI, 1.30‐5.57) as facilitators for discussing AD with physicians, and PPS ≤ 90 (OR, 0.51; 95% CI, 0.26‐0.98) as a barrier. CONCLUSIONS: Our study indicates that patients’ future QOL concerns, a long period of visit to a hospital, and the presence of physical symptoms were associated with the willingness of noncancer patients to discuss AD with PCPs. John Wiley and Sons Inc. 2019-02-20 /pmc/articles/PMC6498101/ /pubmed/31065472 http://dx.doi.org/10.1002/jgf2.238 Text en © 2019 The Authors. Journal of General and Family Medicine published by John Wiley & Sons Australia, Ltd on behalf of Japan Primary Care Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Hamada, Shuhei
Haruta, Junji
Hamano, Jun
Maeno, Takami
Maeno, Tetsuhiro
Associated factors for discussing advance directives with family physicians by noncancer outpatients in Japan
title Associated factors for discussing advance directives with family physicians by noncancer outpatients in Japan
title_full Associated factors for discussing advance directives with family physicians by noncancer outpatients in Japan
title_fullStr Associated factors for discussing advance directives with family physicians by noncancer outpatients in Japan
title_full_unstemmed Associated factors for discussing advance directives with family physicians by noncancer outpatients in Japan
title_short Associated factors for discussing advance directives with family physicians by noncancer outpatients in Japan
title_sort associated factors for discussing advance directives with family physicians by noncancer outpatients in japan
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498101/
https://www.ncbi.nlm.nih.gov/pubmed/31065472
http://dx.doi.org/10.1002/jgf2.238
work_keys_str_mv AT hamadashuhei associatedfactorsfordiscussingadvancedirectiveswithfamilyphysiciansbynoncanceroutpatientsinjapan
AT harutajunji associatedfactorsfordiscussingadvancedirectiveswithfamilyphysiciansbynoncanceroutpatientsinjapan
AT hamanojun associatedfactorsfordiscussingadvancedirectiveswithfamilyphysiciansbynoncanceroutpatientsinjapan
AT maenotakami associatedfactorsfordiscussingadvancedirectiveswithfamilyphysiciansbynoncanceroutpatientsinjapan
AT maenotetsuhiro associatedfactorsfordiscussingadvancedirectiveswithfamilyphysiciansbynoncanceroutpatientsinjapan